Literature DB >> 15149723

Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.

Yasuhiro Nakamura1, Takashi Suzuki, Yasuhiro Miki, Chika Tazawa, Kumiko Senzaki, Takuya Moriya, Haruo Saito, Tadashi Ishibashi, Shoki Takahashi, Shogo Yamada, Hironobu Sasano.   

Abstract

Estrogen has been postulated to exert direct anti-atherogenic effects via binding to estrogen receptors (ERs) in vascular smooth muscle cells (VSMCs). Therefore, we believe it is important to examine the status of ER expression in the human cardiovascular system and its disorders. In this study, we first evaluated the relative abundance of messenger RNA (mRNA) of both ER subtypes (ERalpha and ERbeta) in the human aorta using reverse transcription followed by quantitative polymerase chain reaction (RT-qPCR). We then examined the immunolocalization of both ERs in VSMCs of human atherosclerotic lesions. In order to examine which ER subtype was associated with the anti-atherogenic effects of estrogen, we examined the effects of estrogen in two VSMC cell lines, one positive only for ERalpha and the other positive only for ERbeta. The relative abundance of mRNAs for both ERs was higher in female aorta with a mild degree of atherosclerosis than in female aorta with a severe degree of atherosclerosis (P < 0.05). In addition, the number of ERalpha and/or ERbeta double positive cells in the neointima was higher in female aorta with a mild degree of atherosclerosis than in female aorta with severe atherosclerosis (P < 0.05). Our in vitro study found that estradiol was able to significantly inhibit the proliferation of ERalpha positive VSMCs but not ERbeta positive VSMCs (P < 0.05). Moreover, estradiol was found to significantly suppress proliferating cell nuclear antigen (PCNA) mRNA levels in ERalpha positive VSMCs compared to that of ERbeta positive VSMCs, consistent with the findings of cell proliferation. Results from this study suggest that estrogens can inhibit the proliferation of VSMCs through ERalpha, especially in pre-menopausal women. Our study also indicates that decreased levels of ER, especially ERalpha, in the female atherosclerotic neointima may be associated with progression of atherosclerotic changes. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149723     DOI: 10.1016/j.mce.2004.02.013

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  21 in total

1.  Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males.

Authors:  Adriana Laser; Abhijit Ghosh; Karen Roelofs; Omar Sadiq; Brendan McEvoy; Paul DiMusto; Jon Eliason; Gilbert R Upchurch
Journal:  J Surg Res       Date:  2013-08-18       Impact factor: 2.192

2.  MDM2: a novel mineralocorticoid-responsive gene involved in aldosterone-induced human vascular structural remodeling.

Authors:  Yasuhiro Nakamura; Saya Suzuki; Takashi Suzuki; Katsuhiko Ono; Ikumi Miura; Fumitoshi Satoh; Takuya Moriya; Haruo Saito; Shogo Yamada; Sadayoshi Ito; Hironobu Sasano
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Vascular effects of estrogenic menopausal hormone therapy.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Rev Recent Clin Trials       Date:  2012-02

4.  Rapid estrogen receptor signaling is essential for the protective effects of estrogen against vascular injury.

Authors:  Sophie J Bernelot Moens; Gavin R Schnitzler; Moriah Nickerson; Huiming Guo; Kazutaka Ueda; Qing Lu; Mark J Aronovitz; Heather Nickerson; Wendy E Baur; Ulla Hansen; Lakshmanan K Iyer; Richard H Karas
Journal:  Circulation       Date:  2012-09-20       Impact factor: 29.690

Review 5.  Epigenetic regulation of smooth muscle cell plasticity.

Authors:  Renjing Liu; Kristen L Leslie; Kathleen A Martin
Journal:  Biochim Biophys Acta       Date:  2014-06-15

6.  Resveratrol promotes endothelial cell wound healing under laminar shear stress through an estrogen receptor-α-dependent pathway.

Authors:  Arif Yurdagul; James J Kleinedler; Marshall C McInnis; Alok R Khandelwal; Allyson L Spence; A Wayne Orr; Tammy R Dugas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

Review 7.  Estrogen and the female heart.

Authors:  A A Knowlton; D H Korzick
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

8.  Rapid recruitment of temporally distinct vascular gene sets by estrogen.

Authors:  Katrin K Schnoes; Iris Z Jaffe; Lakshmanan Iyer; Alexandra Dabreo; Mark Aronovitz; Brenna Newfell; Ulla Hansen; Giuseppe Rosano; Michael E Mendelsohn
Journal:  Mol Endocrinol       Date:  2008-09-11

9.  Hormone therapy is associated with preserved smooth muscle structure and dilation in the arterial vasculature of the leg in older women.

Authors:  Beth A Parker; Sandra L Smithmyer; David N Proctor
Journal:  Maturitas       Date:  2008-01-20       Impact factor: 4.342

10.  Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation.

Authors:  Hui Joyce Li; Zaffar Haque; Qing Lu; Li Li; Richard Karas; Michael Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.